Perilipin-1 (D1D8) Rabbit Monoclonal Ant… and 6 more items

The University of Nebraska Medical Center, a state agency, awarded a purchase order (PO) valued at $4,288.00 to Cell Signaling Technology Inc., a Boston, Massachusetts-based vendor, on June 3, 2026. The contract encompasses seven distinct research-grade antibody products with delivery scheduled for June 10, 2026. The procured items include monoclonal antibodies targeting cellular signaling proteins: Perilipin-1, mammalian target of rapamycin (mTOR), adenosine monophosphate-activated protein kinase (AMPK) alpha, phosphorylated mTOR, S6 ribosomal protein, phosphorylated S6 ribosomal protein, and phosphorylated AMPK alpha. Each line item was ordered in a quantity of one unit at unit prices ranging from $368.00 to $1,070.00.

Performance of the contract occurs at the University of Nebraska Medical Center's General Supply facility in Omaha, Nebraska. Payment terms are Net 30 with Free on Board (F.O.B.) Destination shipping, requiring the vendor to prepay freight charges. The vendor is obligated to acknowledge acceptance of the purchase order within ten days of issuance. These biological research reagents support scientific investigation and analysis activities at the contracting organization.